Takashi Ogura
- Risk factors of acute exacerbation of idiopathic pulmonary fibrosis-extended analysis of the pirfenidone trial in JapanBy Hiroyuki Taniguchi, Yasuhiro Kondoh, Masahito Ebina, Arata Azuma, Takashi Ogura, Moritaka Suga, Yoshio Taguchi, Hiroki Takahashi, Koichiro Nakata, Atuhiko Sato, Yukihiko Sugiyama, Shoji Kudoh and Toshihiro NukiwaHiroyuki Taniguchi1Dept. of Respiratory Medicine and Allergy, Tosei General Hospital, Seto, Aichi, JapanYasuhiro Kondoh1Dept. of Respiratory Medicine and Allergy, Tosei General Hospital, Seto, Aichi, JapanMasahito Ebina2Dept. of Respiratory Medicine, Tohoku University Graduate School of Medicine, Sendai, JapanArata Azuma3Dept. of Internal Medicine, Nippon Medical School, Tokyo, JapanTakashi Ogura4Dept. of Respiratory Medicine, Kanagawa Cardiovascular and Respiratory Center, Yokohama, JapanMoritaka Suga5Dept. of Respiratory Medicine, Saiseikai Kumamoto Hospital, Kumamoto, JapanYoshio Taguchi6Dept. of Respiratory Medicine, Tenri Hospital, Tenri, JapanHiroki Takahashi7Third Dept. of Internal Medicine, Sapporo Medical University of Medicine, Sapporo, JapanKoichiro Nakata8Dept. of Respiratory Medicine, Nakata Clinic, Tokyo, JapanAtuhiko Sato9Dept. of Respiratory Medicine, Medicine Kyoto Preventive, Kyoto, JapanYukihiko Sugiyama10Division of Pulmonary Medicine, Dept. of Medicine, Jichi Medical University, Tochigi, JapanShoji Kudoh3Dept. of Internal Medicine, Nippon Medical School, Tokyo, JapanToshihiro Nukiwa2Dept. of Respiratory Medicine, Tohoku University Graduate School of Medicine, Sendai, Japan
- Comparison of efficacy of respiratory rehabilitation in patients with COPD and interstitial lung diseaseBy Atsuhito Nakazawa, Takeshi Shinohara, Eri Hagiwara, Kaori Tsuruta, Takuma Sasaki, Takashi Ogura and Hiroshi TakahashiAtsuhito Nakazawa1Department of Respiratory Medicine, Kanagawa Cardiovascular and Respiratory Center, Yokohama, JapanTakeshi Shinohara1Department of Respiratory Medicine, Kanagawa Cardiovascular and Respiratory Center, Yokohama, JapanEri Hagiwara1Department of Respiratory Medicine, Kanagawa Cardiovascular and Respiratory Center, Yokohama, JapanKaori Tsuruta2Department of Rehabilitation Medicine, Kanagawa Cardiovascular and Respiratory Center, Yokohama, JapanTakuma Sasaki2Department of Rehabilitation Medicine, Kanagawa Cardiovascular and Respiratory Center, Yokohama, JapanTakashi Ogura1Department of Respiratory Medicine, Kanagawa Cardiovascular and Respiratory Center, Yokohama, JapanHiroshi Takahashi1Department of Respiratory Medicine, Kanagawa Cardiovascular and Respiratory Center, Yokohama, Japan
- Promising effect of PMX-DHP absorption therapy for acute exacerbation of IPFBy Arata Azuma, Shinji Abe, Takashi Ogura, Hiroshi Mukae, Hiroyuki Taniguchi, Masashi Bando and Yukihiko SugiyamaArata Azuma1Division of Respiratory Medicine, Infection and Oncology, Nippon Medical School, Tokyo, JapanShinji Abe1Division of Respiratory Medicine, Infection and Oncology, Nippon Medical School, Tokyo, JapanTakashi Ogura2Respiratory Medicine, Kanagawa Cardiovascuiar and Respiratory Center, Yokohama, Kanagawa, JapanHiroshi Mukae3Department of Respiratory Medicine, University of Occupational and Environmental Health, Kitakyushu, Fukuoka, JapanHiroyuki Taniguchi4Division of Respiratory Medicine, Allergic Internal Medicine, Tosei General Hospital, Seto, Aichi, JapanMasashi Bando5Department of Pulmonary Medicine, Jichi Medical University, Shimotsuke, Tochigi, JapanYukihiko Sugiyama5Department of Pulmonary Medicine, Jichi Medical University, Shimotsuke, Tochigi, Japan
- Antimicrobial resistance genotype trends and association with host clinical characteristics in respiratory isolates of haemophilus influenzaeBy Eri Hagiwara, Noriko Tsuchiya, Takahiro Enomoto, Tomohisa Baba, Takeshi Shinohara, Ryuichi Nishihira, Shigeru Komatsu, Terufumi Kato, Takashi Ogura and Hiroshi TakahashiEri HagiwaraDepartment of Respiratory Medicine, Kanagawa Cardiovascular and Respiratory Center, Yokohama, JapanNoriko TsuchiyaDepartment of Respiratory Medicine, Kanagawa Cardiovascular and Respiratory Center, Yokohama, JapanTakahiro EnomotoDepartment of Respiratory Medicine, Kanagawa Cardiovascular and Respiratory Center, Yokohama, JapanTomohisa BabaDepartment of Respiratory Medicine, Kanagawa Cardiovascular and Respiratory Center, Yokohama, JapanTakeshi ShinoharaDepartment of Respiratory Medicine, Kanagawa Cardiovascular and Respiratory Center, Yokohama, JapanRyuichi NishihiraDepartment of Respiratory Medicine, Kanagawa Cardiovascular and Respiratory Center, Yokohama, JapanShigeru KomatsuDepartment of Respiratory Medicine, Kanagawa Cardiovascular and Respiratory Center, Yokohama, JapanTerufumi KatoDepartment of Respiratory Medicine, Kanagawa Cardiovascular and Respiratory Center, Yokohama, JapanTakashi OguraDepartment of Respiratory Medicine, Kanagawa Cardiovascular and Respiratory Center, Yokohama, JapanHiroshi TakahashiDepartment of Respiratory Medicine, Kanagawa Cardiovascular and Respiratory Center, Yokohama, Japan
- Proposal for revised clasification of disease severity of idiopathic pulmonary fibrosis in JapanBy Hiroyuki Taniguchi, Kensuke Kataoka, Yasuhiro Kondoh, Sakae Homma, Michiaki Mishima, Yoshikazu Inoue, Takashi Ogura, Masashi Bando, Koichi Hagiwara, Hiroki Takahashi, Kingo Chida, Kazuma Kishi and Yukihiko SugiyamaHiroyuki Taniguchi1Dept. of Respiratory Medicine and Allergy, Tosei General Hospital, Seto, Aichi, JapanKensuke Kataoka1Dept. of Respiratory Medicine and Allergy, Tosei General Hospital, Seto, Aichi, JapanYasuhiro Kondoh1Dept. of Respiratory Medicine and Allergy, Tosei General Hospital, Seto, Aichi, JapanSakae Homma2Dept. of Respiratory Medicine, Toho University Omori Medical Center, Tokyo, JapanMichiaki Mishima3Dept. of Respiratory Medicine, Kyoto University Hospital, Kyoto, JapanYoshikazu Inoue4Clinical Research Center, National Hospital Organization Kinki-Chuo Chest Medical Center, Osaka, JapanTakashi Ogura5Dept. of Respiratory Medicine, Kanagawa Cardiovascular and Respiratory Center, Kanagawa Cardiovascular and Respiratory Center, Yokohama, JapanMasashi Bando6Division of Pulmonary Medicine, Dept. of Medicine, Jichi Medical University, Tochigi, JapanKoichi Hagiwara7Dept. of Respiratory Medicine, Saitama Medical University, Saitama, JapanHiroki Takahashi83rd Dept. of Internal Medicine, Sapporo Medical University School of Medicine, Sapporo, JapanKingo Chida92nd Dept. of Internal Medicine, Hamamatsu University School of Medicine, Hamamatsu, JapanKazuma Kishi10Dept. of Respiratory Medicine, Respiratory Center, Toranomon Hospital, Tokyo, JapanYukihiko Sugiyama6Division of Pulmonary Medicine, Dept. of Medicine, Jichi Medical University, Tochigi, Japan
- Lung-limited IgG4-related disease: A new form of IgG4-related disease?By Yuko Waseda, Shoko Matsui, Hiroshi Yamamoto, Takashi Ogura, Akira Hebisawa, Fumikazu Sakai, Yasuhiro Terasaki, Yasuyuki Kurihara, Kingo Chida, Yohei Yatagai, Fumiya Fukushima, Mutsuo Kuba, Koichi Miyashita, Mikio Toyoshima, Masayuki Ishida, Hiroki Hayashi, Yutaka Tsuchiya, Keishi Ohishi, Yoshiaki Morio, Kenji Konishi and Masaki FujimuraYuko Waseda1Respiratory Medicine, Kanazawa University School of Medicine, Kanazawa, Ishikawa, JapanShoko Matsui2Health Administration Center, University of Toyama, Toyama, JapanHiroshi Yamamoto3Respiratory Medicine, Shinshu University School of Medicine, Matsumoto, Nagano, JapanTakashi Ogura4Respiratory Medicine, Kanagawa Cardiovascular and Respiratory Center, Yokohama, Kanagawa, JapanAkira Hebisawa5Clinical Laboratory, National Hospital Organization Tokyo Hospital, Kiyose, Tokyo, JapanFumikazu Sakai6Radiology, Saitama Medical University International Medical Center, Saitama, JapanYasuhiro Terasaki7Analytic Human Pathology, Nippon Medical School, Bunkyoku, Tokyo, JapanYasuyuki Kurihara8Radiology, St. Marianna University School of Medicine, Kawasaki, Kanagawa, JapanKingo Chida9Respiratory Medicine, Hamamatsu Univercity School of Medicine, Hamamatsu, Shizuoka, JapanYohei Yatagai10Respiratory Medicine, NHO Ibarakihigashi National Hospital, Nakagun, Ibaraki, JapanFumiya Fukushima11Respiratory Medicine, Dokkyo Medical University, Shimotsugagun, Tochigi, JapanMutsuo Kuba12Respiratory Medicine, NHO Okinawa Hospiral, Minowan, Okinawa, JapanKoichi Miyashita13Respiratory Medicine, Fukui Saiseikai Hospital, Fukui, JapanMikio Toyoshima14Respiratory Medicine, Hamamatsu Rosai Hospital, Hamamatsu, Shizuoka, JapanMasayuki Ishida15Respiratory Medicine, Nagasaki University Hospital, Nagasaki, JapanHiroki Hayashi16Respiratory Medicine, Nippon Medical School, Bunkyoku, Tokyo, JapanYutaka Tsuchiya17Respiratory Medicine, Showa University Fujigaoka Hospital, Yokohama, Kanagawa, JapanKeishi Ohishi18Respiratory Medicine, NHO Yamaguchi Ube Medical Center, Ube, Yamaguchi, JapanYoshiaki Morio19Respiratory Medicine, Juntendo University School of Medicine, Bunkyoku, Tokyo, JapanKenji Konishi20Respiratory Medicine, Seirei Yokohama Hospital, Yokohama, Kanagawa, JapanMasaki Fujimura1Respiratory Medicine, Kanazawa University School of Medicine, Kanazawa, Ishikawa, Japan
- Distinct clinical characteristics of idiopathic interstitial pneumonia predominant in upper lobesBy Tsuneyuki Oda, Eri Hagiwara, Tomohisa Baba, Hideya Kitamura, Atsuhito Nakazawa and Takashi OguraTsuneyuki Oda1Department of Respiratory Medicine, Kanagawa Cardiovascular and Respiratory Center, Yokohama, JapanEri Hagiwara1Department of Respiratory Medicine, Kanagawa Cardiovascular and Respiratory Center, Yokohama, JapanTomohisa Baba1Department of Respiratory Medicine, Kanagawa Cardiovascular and Respiratory Center, Yokohama, JapanHideya Kitamura1Department of Respiratory Medicine, Kanagawa Cardiovascular and Respiratory Center, Yokohama, JapanAtsuhito Nakazawa1Department of Respiratory Medicine, Kanagawa Cardiovascular and Respiratory Center, Yokohama, JapanTakashi Ogura1Department of Respiratory Medicine, Kanagawa Cardiovascular and Respiratory Center, Yokohama, Japan
- Efficacy of pulmonary rehabilitation in patients with interstitial lung diseaseBy Atsuhito Nakazawa, Eri Hagiwara, Ou Yamaguchi, Ryo Ogata, Takeshi Shinohara, Yusuke Matsumoto, Kaori Tsuruta, Takuma Sasaki and Takashi OguraAtsuhito Nakazawa1Department of Respiratory Medicine, Kanagawa Cardiovascular and Respiratory Center, Yokohama, JapanEri Hagiwara1Department of Respiratory Medicine, Kanagawa Cardiovascular and Respiratory Center, Yokohama, JapanOu Yamaguchi1Department of Respiratory Medicine, Kanagawa Cardiovascular and Respiratory Center, Yokohama, JapanRyo Ogata1Department of Respiratory Medicine, Kanagawa Cardiovascular and Respiratory Center, Yokohama, JapanTakeshi Shinohara1Department of Respiratory Medicine, Kanagawa Cardiovascular and Respiratory Center, Yokohama, JapanYusuke Matsumoto2Department of Rehabilitation Medicine, Kanagawa Cardiovascular and Respiratory Center, Yokohama, JapanKaori Tsuruta2Department of Rehabilitation Medicine, Kanagawa Cardiovascular and Respiratory Center, Yokohama, JapanTakuma Sasaki2Department of Rehabilitation Medicine, Kanagawa Cardiovascular and Respiratory Center, Yokohama, JapanTakashi Ogura1Department of Respiratory Medicine, Kanagawa Cardiovascular and Respiratory Center, Yokohama, Japan
- Unexpectedly high incidence of pneumothorax in patients with pulmonary Mycobacterium avium complex infectionBy Eri Hagiwara, Atsuhito Nakazawa, Tsuneyuki Oda, Takahiro Enomoto, Tomohisa Baba, Ryuichi Nishihira, Shigeru Komatsu, Terufumi Kato and Takashi OguraEri Hagiwara1Department of Respiratory Medicine, Kanagawa Cardiovascular and Respiratory Center, Yokohama, JapanAtsuhito Nakazawa1Department of Respiratory Medicine, Kanagawa Cardiovascular and Respiratory Center, Yokohama, JapanTsuneyuki Oda1Department of Respiratory Medicine, Kanagawa Cardiovascular and Respiratory Center, Yokohama, JapanTakahiro Enomoto1Department of Respiratory Medicine, Kanagawa Cardiovascular and Respiratory Center, Yokohama, JapanTomohisa Baba1Department of Respiratory Medicine, Kanagawa Cardiovascular and Respiratory Center, Yokohama, JapanRyuichi Nishihira1Department of Respiratory Medicine, Kanagawa Cardiovascular and Respiratory Center, Yokohama, JapanShigeru Komatsu1Department of Respiratory Medicine, Kanagawa Cardiovascular and Respiratory Center, Yokohama, JapanTerufumi Kato1Department of Respiratory Medicine, Kanagawa Cardiovascular and Respiratory Center, Yokohama, JapanTakashi Ogura1Department of Respiratory Medicine, Kanagawa Cardiovascular and Respiratory Center, Yokohama, Japan
- A clinicopathological review of interstitial pneumonia with marked IgG4 positive plasma cells infiltrationBy Satoshi Ikeda, Tomohisa Baba, Machiko Arita, Tamiko Takemura, Takashi Ogura and Tadashi IshidaSatoshi Ikeda1Respiratory Medicine, Kurashiki Central Hospital, Kurashiki, Okayama, JapanTomohisa Baba2Respiratory Medicine, Kanagawa Cardiovascular and Respiratory Center, Yokohama, Kanagawa, JapanMachiko Arita1Respiratory Medicine, Kurashiki Central Hospital, Kurashiki, Okayama, JapanTamiko Takemura3Pathology, Japanese Red Cross Medical Center, Hiroo, Shibuya-ku, Tokyo, JapanTakashi Ogura2Respiratory Medicine, Kanagawa Cardiovascular and Respiratory Center, Yokohama, Kanagawa, JapanTadashi Ishida1Respiratory Medicine, Kurashiki Central Hospital, Kurashiki, Okayama, Japan
- Analysis of multicentric Castleman's disease (MCD) with pulmonary lesionsBy Soichiro Ikushima, Yasuhiro Terasaki, Akira Hebisawa, Takeshi Johko, Fumikazu Sakai, Norihiro Nishimoto, Takashi Ogura, Yasunori Ohta, Haruyuki Ishii, Shoko Matsui, Hiroshi Yamamoto, Yasunori Ichimura, Masuo Ujita, Tetsuharu Kawamura, Masashi Bando, Hiroshi Ishimoto, Shinyu Izumi, Norihiko Hata, Keisuke Tomii, Isoko Owan, Hiroshi Kimura, Yuko Komase, Yasuo Matsuzawa, Machiko Arita and Akira ShirakiSoichiro Ikushima1Respiratory Medicine, Japanese Red Cross Medical Center, Tokyo, JapanYasuhiro Terasaki2Pathology, Nippon Medical School, Tokyo, JapanAkira Hebisawa3Pathology, NHO Tokyo National Hospital, Tokyo, JapanTakeshi Johko4Radiology, Kinki Central Hospital, Itami, JapanFumikazu Sakai5Diagnostic Radiology, Saitama Medical University, Saitama, JapanNorihiro Nishimoto6Laboratory of Immune Regulation, Wakayama Medical University, Osaka, JapanTakashi Ogura7Respiratory Medicine, Kanagawa Cardiovascular and Respiratory Center, Kanagawa, JapanYasunori Ohta8Pathology, Toranomon Hospital, Tokyo, JapanHaruyuki Ishii9Respiratory Medicine, Kyorin University, Tokyo, JapanShoko Matsui10Respiratory Medicine, Toyama University School of Medicine, Toyama, JapanHiroshi Yamamoto11First Department of Internal Medicine, Shinshyu University School of Medicine, Matsumoto, JapanYasunori Ichimura12Respirology, Chiba University, Chiba, JapanMasuo Ujita13Radiology, NHO Nishigunma National Hospital, Shibukawa, JapanTetsuharu Kawamura14Respiratory Medicine, NHO Himeji Medical Center, Himeji, JapanMasashi Bando15Respiratory Medicine, Jichi Medical University, Shimotsuke, JapanHiroshi Ishimoto16Respiratory Medicine, University of Occupatioal and Environmental Health, Kitakyushyu, JapanShinyu Izumi17Respiratory Medicine, National Center Global Health and Medicine, Tokyo, JapanNorihiko Hata18Respiratory Medicine, Kawaguchi City Medical Center, Kawaguchi, JapanKeisuke Tomii19Respiratory Medicine, Kobe City Medical Center General Hospital, Kobe, JapanIsoko Owan20Respiratory Medicine, Okinawa National Hospital, Okinawa, JapanHiroshi Kimura21Second Department of Internal Medicine and Respiratory Medicine, Nara Medical University, Nara, JapanYuko Komase22Respiratory Medicine, St. Marianna University School of Medicine, Yokohama City Seibu Hospital, Yokohama, JapanYasuo Matsuzawa23Respiratory Medicine, Toho-univ Medical Center Sakura-Hospital, Sakura, JapanMachiko Arita24Respiratory Medicine, Kurashiki Central Hospital, Kurashiki, JapanAkira Shiraki25Respiratory Medicine, Ogaki Municipal Hospital, Ogaki, Japan
- Never-smoking history as a poor prognostic factor in surgically proven idiopathic pulmonary fibrosisBy Tomohisa Baba, Yasunori Enomoto, Atsuto Nakazawa, Hideya Kitamura, Tsuneyuki Oda, Norikazu Matsuo, Terufumi Kato, Eri Hagiwara, Koji Okudera, Tae Iwasawa, Tamiko Takemura and Takashi OguraTomohisa Baba1Respiratory Medicine, Kanagawa Cardiovascular and Respiratory Center, Yokohama, JapanYasunori Enomoto1Respiratory Medicine, Kanagawa Cardiovascular and Respiratory Center, Yokohama, JapanAtsuto Nakazawa1Respiratory Medicine, Kanagawa Cardiovascular and Respiratory Center, Yokohama, JapanHideya Kitamura1Respiratory Medicine, Kanagawa Cardiovascular and Respiratory Center, Yokohama, JapanTsuneyuki Oda1Respiratory Medicine, Kanagawa Cardiovascular and Respiratory Center, Yokohama, JapanNorikazu Matsuo1Respiratory Medicine, Kanagawa Cardiovascular and Respiratory Center, Yokohama, JapanTerufumi Kato1Respiratory Medicine, Kanagawa Cardiovascular and Respiratory Center, Yokohama, JapanEri Hagiwara1Respiratory Medicine, Kanagawa Cardiovascular and Respiratory Center, Yokohama, JapanKoji Okudera3Pathology, Yokohama City University, Yokohama, JapanTae Iwasawa2Radiology, Kanagawa Cardiovascular and Respiratory Center, Yokohama, JapanTamiko Takemura4Pathology, Japanese Red Cross Medical Center, Tokyo, JapanTakashi Ogura1Respiratory Medicine, Kanagawa Cardiovascular and Respiratory Center, Yokohama, Japan
- Safety and pharmacokinetics of nintedanib and pirfenidone in idiopathic pulmonary fibrosisBy Takashi Ogura, Hiroyuki Taniguchi, Arata Azuma, Yoshikazu Inoue, Yasuhiro Kondoh, Yoshinori Hasegawa, Masashi Bando, Shinji Abe, Yoshiro Mochizuki, Kingo Chida, Matthias Klüglich, Tsuyoshi Fujimoto, Kotaro Okazaki, Yusuke Tadayasu, Wataru Sakamoto and Yukihiko SugiyamaArticle | Published in 2014 in European Respiratory JournalTakashi Ogura1Dept of Respiratory Medicine, Kanagawa Cardiovascular and Respiratory Center, Yokohama, JapanHiroyuki Taniguchi2Dept of Respiratory Medicine and Allergy, Tosei General Hospital, Aichi, JapanArata Azuma3Graduate School of Medicine Nippon Medical School, Tokyo, JapanYoshikazu Inoue4Dept of Diffuse Lung Diseases and Respiratory Failure, Clinical Research Center, National Hospital Organization Kinki-Chuo Chest Medical Center, Osaka, JapanYasuhiro Kondoh2Dept of Respiratory Medicine and Allergy, Tosei General Hospital, Aichi, JapanYoshinori Hasegawa5Dept of Respiratory Medicine, Nagoya University Graduate School of Medicine, Nagoya, JapanMasashi Bando6Division of Pulmonary Medicine, Dept of Medicine, Jichi Medical University, Tochigi, JapanShinji Abe3Graduate School of Medicine Nippon Medical School, Tokyo, JapanYoshiro Mochizuki7Respiratory Medicine, Himeji Medical Center, Himeji, JapanKingo Chida8Second Division, Dept of Internal Medicine, Hamamatsu University School of Medicine, Hamamatsu, JapanMatthias Klüglich9Boehringer Ingelheim Pharma GmbH & Co. KG, Biberach, GermanyTsuyoshi Fujimoto10Nippon Boehringer Ingelheim Co. Ltd, Tokyo, JapanKotaro Okazaki10Nippon Boehringer Ingelheim Co. Ltd, Tokyo, JapanYusuke Tadayasu10Nippon Boehringer Ingelheim Co. Ltd, Tokyo, JapanWataru Sakamoto10Nippon Boehringer Ingelheim Co. Ltd, Tokyo, JapanYukihiko Sugiyama6Division of Pulmonary Medicine, Dept of Medicine, Jichi Medical University, Tochigi, Japan
- Safety and pharmacokinetics of nintedanib and pirfenidone in idiopathic pulmonary fibrosisBy Takashi Ogura, Hiroyuki Taniguchi, Arata Azuma, Yoshikazu Inoue, Yasuhiro Kondoh, Yoshinori Hasegawa, Masashi Bando, Shinji Abe, Yoshiro Mochizuki, Kingo Chida, Matthias Klüglich, Tsuyoshi Fujimoto, Kotaro Okazaki, Yusuke Tadayasu, Wataru Sakamoto and Yukihiko SugiyamaArticle | Published in 2014 in European Respiratory JournalTakashi Ogura1Dept of Respiratory Medicine, Kanagawa Cardiovascular and Respiratory Center, Yokohama, JapanHiroyuki Taniguchi2Dept of Respiratory Medicine and Allergy, Tosei General Hospital, Aichi, JapanArata Azuma3Graduate School of Medicine Nippon Medical School, Tokyo, JapanYoshikazu Inoue4Dept of Diffuse Lung Diseases and Respiratory Failure, Clinical Research Center, National Hospital Organization Kinki-Chuo Chest Medical Center, Osaka, JapanYasuhiro Kondoh2Dept of Respiratory Medicine and Allergy, Tosei General Hospital, Aichi, JapanYoshinori Hasegawa5Dept of Respiratory Medicine, Nagoya University Graduate School of Medicine, Nagoya, JapanMasashi Bando6Division of Pulmonary Medicine, Dept of Medicine, Jichi Medical University, Tochigi, JapanShinji Abe3Graduate School of Medicine Nippon Medical School, Tokyo, JapanYoshiro Mochizuki7Respiratory Medicine, Himeji Medical Center, Himeji, JapanKingo Chida8Second Division, Dept of Internal Medicine, Hamamatsu University School of Medicine, Hamamatsu, JapanMatthias Klüglich9Boehringer Ingelheim Pharma GmbH & Co. KG, Biberach, GermanyTsuyoshi Fujimoto10Nippon Boehringer Ingelheim Co. Ltd, Tokyo, JapanKotaro Okazaki10Nippon Boehringer Ingelheim Co. Ltd, Tokyo, JapanYusuke Tadayasu10Nippon Boehringer Ingelheim Co. Ltd, Tokyo, JapanWataru Sakamoto10Nippon Boehringer Ingelheim Co. Ltd, Tokyo, JapanYukihiko Sugiyama6Division of Pulmonary Medicine, Dept of Medicine, Jichi Medical University, Tochigi, Japan
- Clinical features of usual interstitial pneumonia with anti-neutrophil cytoplasmic antibody in comparison with idiopathic pulmonary fibrosisBy Chiaki Hosoda, Tomohisa Baba, Hideya Kitamura, Eri Hagiwara, Tae Iwasawa, Noriyo Yanagawa, Fumikazu Sakai, Koji Okudela, Tamiko Takemura and Takashi OguraChiaki Hosoda1Department of Respiratory Medecine, Kanagawa Cardiovascular and Respiratory Centor, Yokohama, Kanagawa, JapanTomohisa Baba1Department of Respiratory Medecine, Kanagawa Cardiovascular and Respiratory Centor, Yokohama, Kanagawa, JapanHideya Kitamura1Department of Respiratory Medecine, Kanagawa Cardiovascular and Respiratory Centor, Yokohama, Kanagawa, JapanEri Hagiwara1Department of Respiratory Medecine, Kanagawa Cardiovascular and Respiratory Centor, Yokohama, Kanagawa, JapanTae Iwasawa2Department of Radiology, Kanagawa Cardiovascular and Respiratory Centor, Yokohama, Kanagawa, JapanNoriyo Yanagawa3Department of Radiology, Tokyo Metropolitan Cancer and Infectious Diseases Center Komagome Hospital, Tokyo, JapanFumikazu Sakai4Department of Radiology, Saitama International Medical Center, Saitama Medical University, Saitama, JapanKoji Okudela5Department of Pathology, Yokohama City University Graduate School of Medicine, Yokohama, Kanagawa, JapanTamiko Takemura6Department of Pathology, Japanese Red Cross Medical Center, Tokyo, JapanTakashi Ogura1Department of Respiratory Medecine, Kanagawa Cardiovascular and Respiratory Centor, Yokohama, Kanagawa, Japan
- Acute exacerbation of idiopathic pulmonary fibrosis: Analysis in a post-marketing surveillance of pirfenidoneBy Hiroyuki Taniguchi, Arata Azuma, Takashi Ogura, Yoshikazu Inoue, Kingo Chida, Masashi Bando, Shinichi Kakutani, Shuichiro Inagaki, Moritaka Suga, Yukihiko Sugiyama, Shoji Kudoh and Toshihiro NukiwaHiroyuki Taniguchi1Department of Respiratory Medicine and Allergy, Tosei General Hospital, Seto, Aichi, JapanArata Azuma2Department of Pulmonary Medicine and Oncology, Nippon Medical School, Tokyo, JapanTakashi Ogura3Department of Respiratory Medicine, Kanagawa Cardiovascular and Respiratory Center, Yokohama, Kanagawa, JapanYoshikazu Inoue4Department of Diffuse Lung Diseases and Respiratory Failure, National Hospital Organization Kinki-Chuo Chest Medical Center, Sakai, Osaka, JapanKingo Chida5Department of Respiratory Medicine, Hamamatsu Toyooka Hospital, Hamamatsu, Shizuoka, JapanMasashi Bando6Division of Pulmonary Medicine, Department of Medicine, Jichi Medical University, Shimotsuke, Tochigi, JapanShinichi Kakutani7Center for Statistics and Analysis, Shionogi & Co., Ltd, Osaka, JapanShuichiro Inagaki7Center for Statistics and Analysis, Shionogi & Co., Ltd, Osaka, JapanMoritaka Suga8Center for Preventive Medicine, Saiseikai Kumamoto Hospital, Kumamoto, JapanYukihiko Sugiyama6Division of Pulmonary Medicine, Department of Medicine, Jichi Medical University, Shimotsuke, Tochigi, JapanShoji Kudoh9Department of Respiratory Medicine, Fukujuji Hospital, Kiyose, Tokyo, JapanToshihiro Nukiwa10Department of Respiratory Medicine, South Miyagi Medical Center, Shibata, Miyagi, Japan
- Antibiotic resistance genotype trend and association with host clinical characteristics in respiratory isolates of streptococcus pneumoniaeBy Eri Hagiwara, Yoshihiro Suido, Atsuhito Nakazawa, Akimasa Sekine, Hideya Kitamura, Tomohisa Baba, Takeshi Shinohara, Ryuichi Nishihira, Shigeru Komatsu, Terufumi Kato and Takashi OguraEri Hagiwara1Department of Respiratory Medicine, Kanagawa Cardiovascular and Respiratory Center, Yokohama, JapanYoshihiro Suido1Department of Respiratory Medicine, Kanagawa Cardiovascular and Respiratory Center, Yokohama, JapanAtsuhito Nakazawa1Department of Respiratory Medicine, Kanagawa Cardiovascular and Respiratory Center, Yokohama, JapanAkimasa Sekine1Department of Respiratory Medicine, Kanagawa Cardiovascular and Respiratory Center, Yokohama, JapanHideya Kitamura1Department of Respiratory Medicine, Kanagawa Cardiovascular and Respiratory Center, Yokohama, JapanTomohisa Baba1Department of Respiratory Medicine, Kanagawa Cardiovascular and Respiratory Center, Yokohama, JapanTakeshi Shinohara1Department of Respiratory Medicine, Kanagawa Cardiovascular and Respiratory Center, Yokohama, JapanRyuichi Nishihira1Department of Respiratory Medicine, Kanagawa Cardiovascular and Respiratory Center, Yokohama, JapanShigeru Komatsu1Department of Respiratory Medicine, Kanagawa Cardiovascular and Respiratory Center, Yokohama, JapanTerufumi Kato1Department of Respiratory Medicine, Kanagawa Cardiovascular and Respiratory Center, Yokohama, JapanTakashi Ogura1Department of Respiratory Medicine, Kanagawa Cardiovascular and Respiratory Center, Yokohama, Japan
- The clinical features of 13 patients with interstitial pneumonia with positive anti-glycyl-tRNA synthetase autoantibodiesBy Hajime Sasano, Hideya Kitamura, Tomohisa Baba, Yasunori Enomoto, Norikazu Matsuo, Eri Hagiwara, Miyako Nakagawa, Etsuko Iwata, Koji Okudera, Shinji Sato, Yasuo Suzuki, Tae Iwasawa, Tamiko Takemura and Takashi OguraHajime Sasano1Respiratory Medicine, Kanagawa Cardiovascular and Respiratory Center, Yokohama, Kanagawa, JapanHideya Kitamura1Respiratory Medicine, Kanagawa Cardiovascular and Respiratory Center, Yokohama, Kanagawa, JapanTomohisa Baba1Respiratory Medicine, Kanagawa Cardiovascular and Respiratory Center, Yokohama, Kanagawa, JapanYasunori Enomoto1Respiratory Medicine, Kanagawa Cardiovascular and Respiratory Center, Yokohama, Kanagawa, JapanNorikazu Matsuo1Respiratory Medicine, Kanagawa Cardiovascular and Respiratory Center, Yokohama, Kanagawa, JapanEri Hagiwara1Respiratory Medicine, Kanagawa Cardiovascular and Respiratory Center, Yokohama, Kanagawa, JapanMiyako Nakagawa5Rheumatology, Tokai University School of Medicine, Isehara, Kanagawa, JapanEtsuko Iwata5Rheumatology, Tokai University School of Medicine, Isehara, Kanagawa, JapanKoji Okudera3Pathology, Yokohama City University Graduate School of Medicine, Yokohama, Kanagawa, JapanShinji Sato5Rheumatology, Tokai University School of Medicine, Isehara, Kanagawa, JapanYasuo Suzuki5Rheumatology, Tokai University School of Medicine, Isehara, Kanagawa, JapanTae Iwasawa2Radiological, Kanagawa Cardiovascular and Respiratory Center, Yokohama, Kanagawa, JapanTamiko Takemura4Pathology, Japanese Red Cross Medical Center, Shibuya, Tokyo, JapanTakashi Ogura1Respiratory Medicine, Kanagawa Cardiovascular and Respiratory Center, Yokohama, Kanagawa, Japan
- Safety and pharmacokinetics of nintedanib and pirfenidone in idiopathic pulmonary fibrosisBy Takashi Ogura, Hiroyuki Taniguchi, Arata Azuma, Yoshikazu Inoue, Yasuhiro Kondoh, Yoshinori Hasegawa, Masashi Bando, Shinji Abe, Yoshiro Mochizuki, Kingo Chida, Matthias Klüglich, Tsuyoshi Fujimoto, Kotaro Okazaki, Yusuke Tadayasu, Wataru Sakamoto and Yukihiko SugiyamaTakashi Ogura1Dept of Respiratory Medicine, Kanagawa Cardiovascular and Respiratory Center, Yokohama, JapanHiroyuki Taniguchi2Dept of Respiratory Medicine and Allergy, Tosei General Hospital, Aichi, JapanArata Azuma3Graduate School of Medicine Nippon Medical School, Tokyo, JapanYoshikazu Inoue4Dept of Diffuse Lung Diseases and Respiratory Failure, Clinical Research Center, National Hospital Organization Kinki-Chuo Chest Medical Center, Osaka, JapanYasuhiro Kondoh2Dept of Respiratory Medicine and Allergy, Tosei General Hospital, Aichi, JapanYoshinori Hasegawa5Dept of Respiratory Medicine, Nagoya University Graduate School of Medicine, Nagoya, JapanMasashi Bando6Division of Pulmonary Medicine, Dept of Medicine, Jichi Medical University, Tochigi, JapanShinji Abe3Graduate School of Medicine Nippon Medical School, Tokyo, JapanYoshiro Mochizuki7Respiratory Medicine, Himeji Medical Center, Himeji, JapanKingo Chida8Second Division, Dept of Internal Medicine, Hamamatsu University School of Medicine, Hamamatsu, JapanMatthias Klüglich9Boehringer Ingelheim Pharma GmbH & Co. KG, Biberach, GermanyTsuyoshi Fujimoto10Nippon Boehringer Ingelheim Co. Ltd, Tokyo, JapanKotaro Okazaki10Nippon Boehringer Ingelheim Co. Ltd, Tokyo, JapanYusuke Tadayasu10Nippon Boehringer Ingelheim Co. Ltd, Tokyo, JapanWataru Sakamoto10Nippon Boehringer Ingelheim Co. Ltd, Tokyo, JapanYukihiko Sugiyama6Division of Pulmonary Medicine, Dept of Medicine, Jichi Medical University, Tochigi, Japan
- Impact of underlying respiratory diseases on clinical features and prognosis of chronic pulmonary aspergillosisBy Midori Sugisaki, Eri Hagiwara, Hiroyuki Ito, Norikazu Matsuo, Tomohisa Baba, Shigeru Komatsu and Takashi OguraMidori SugisakiDepartment of Respiratory Medicine, Kanagawa Cardiovascular and Respiratory Center, Yokohama, Kanagawa JapanEri HagiwaraDepartment of Respiratory Medicine, Kanagawa Cardiovascular and Respiratory Center, Yokohama, Kanagawa JapanHiroyuki ItoDepartment of Respiratory Medicine, Kanagawa Cardiovascular and Respiratory Center, Yokohama, Kanagawa JapanNorikazu MatsuoDepartment of Respiratory Medicine, Kanagawa Cardiovascular and Respiratory Center, Yokohama, Kanagawa JapanTomohisa BabaDepartment of Respiratory Medicine, Kanagawa Cardiovascular and Respiratory Center, Yokohama, Kanagawa JapanShigeru KomatsuDepartment of Respiratory Medicine, Kanagawa Cardiovascular and Respiratory Center, Yokohama, Kanagawa JapanTakashi OguraDepartment of Respiratory Medicine, Kanagawa Cardiovascular and Respiratory Center, Yokohama, Kanagawa Japan
- Interim analysis of nintedanib in an open-label extension of the INPULSIS® trials (INPULSIS®-ON)By Bruno Crestani, Takashi Ogura, Katy Pelling, Carl Coeck, Manuel Quaresma, Michael Kreuter and Mitchell KayeBruno Crestani1Pneumologie, Hôpital Bichat, Paris, FranceTakashi Ogura2Department of Respiratory Medicine, Kanagawa Cardiovascular and Respiratory Center, Yokohama, Kanagawa JapanKaty Pelling3Statistics, Boehringer Ingelheim Ltd., Bracknell, United KingdomCarl Coeck4Respiratory Diseases, SCS Boehringer Ingelheim Comm.V., Brussels, BelgiumManuel Quaresma5Respiratory Diseases, Boehringer Ingelheim Pharma GmbH & Co. KG., Ingelheim am Rhein, GermanyMichael Kreuter6Department of Pneumology, Thoraxklinik, University of Heidelberg, and Translational Lung Research Center Heidelberg, German Center for Lung Research, Heidelberg, GermanyMitchell Kaye7Minnesota Lung Center, Ltd., Minnesota Lung Center, Ltd., Minneapolis, MN United States
- Clinical course and changes in high-resolution computed tomography findings in patients with idiopathic pulmonary fibrosis without honeycombingBy Hiroyoshi Yamauchi, Masashi Bando, Tomohisa Baba, Kensuke Kataoka, Yoshikazu Inoue, Yoshihito Yamada, Hiroshi Yamamoto, Kentaro Watanabe, Yasuhiro Terasaki, Akira Hebisawa, Yoshinori Kawabata, Takeshi Johkoh, Fumikazu Sakai, Yukihiko Sugiyama and Takashi OguraHiroyoshi Yamauchi1Division of Pulmonary Medicine, Department of Medicine, Jichi Medical University, Tochigi, JapanMasashi Bando1Division of Pulmonary Medicine, Department of Medicine, Jichi Medical University, Tochigi, JapanTomohisa Baba2Department of Respiratory Medicine, Kanagawa Cardiovascular and Respiratory Center, Kanagawa, JapanKensuke Kataoka3Department of Respiratory Medicine and Allergy, Tosei General Hospital, Aichi, JapanYoshikazu Inoue4Department of Diffuse Lung Diseases and Respiratory Failure, Clinical Research Center, National Hospital Organization Kinki-Chuo Chest Medical Center, Osaka, JapanYoshihito Yamada5Department of Respiratory Medicine, JR Tokyo General Hospital, East Japan Railway Company, Tokyo, JapanHiroshi Yamamoto6First Department of Internal Medicine, Shinshu University School of Medicine, Nagano, JapanKentaro Watanabe7Division of Respiratory Medicine, Department of Internal Medicine, Fukuoka University School of Medicine, Fukuoka, JapanYasuhiro Terasaki8Department of Analytic Human Pathology, Nippon Medical School, Tokyo, JapanAkira Hebisawa9Department of Clinical Research, National Hospital Organization Tokyo National Hospital, Tokyo, JapanYoshinori Kawabata10Department of Pathology, Saitama Cardiovascular and Respiratory Center, Saitama, JapanTakeshi Johkoh11Department of Radiology, Kinki Central Hospital of Mutual Aid Association of Public School Teachers, Hyogo, JapanFumikazu Sakai12Department of Diagnostic Radiology, Saitama Medical University International Medical Center, Saitama, JapanYukihiko Sugiyama1Division of Pulmonary Medicine, Department of Medicine, Jichi Medical University, Tochigi, JapanTakashi Ogura2Department of Respiratory Medicine, Kanagawa Cardiovascular and Respiratory Center, Kanagawa, Japan
Buying books on this site
Purchases made on this website are of electronic books only.
About the ERS books
The ERS Monograph is the quarterly book series from the European Respiratory Society. Each Monograph covers a specific area of respiratory medicine, providing in-depth reviews that give clinicians at all levels a concise, comprehensive guide to symptoms, diagnosis and treatment.
The ERS Handbooks are compact guides to broad areas of the respiratory field. Launched in 2010, the series now covers adult, paediatric and sleep respiratory medicine, includes a companion volume of self-assessment questions and features the ERS Practical Handbooks.